Helps explain the weakness but Cooperman dumping at a big loss is probably a good indicator a bottom is in
Hope to have a better feel after Friday options expiration. With such volatility the shorts will cover after positions close then
A buyback can wait. If they can execute on initiatives and deliver on earnings, the stock will at least double in a year
I agree that production will be a whole new ballgame in the second 1/2 of the year. I keep having a vision of ISIS lobbing firing surface to surface missiles (probably US made) into Saudi Arabia's production facilities.
Hello 100+ oil!!! And here we go again.....
Both super hedged for '15 and into '16
Would love your analysis as I hold all 3
Buying June 10 calls
Trading at where the stock was in the money yesterday
Ill take my chances in 4 months
I would hope the PE guys looking for a better exit strategy than dilution. Knowing they have this year covered at 90/bbl and next year 75% should be a nice calling card
Options expiration shennanigans. Look at the manipulative volume.
Next week it will rise back. Cheap shares today
Added 50 million cash in the Q..Marigold is a cash cow.
Non cash charges thrown in.
If the commodity prices rise SSRI is well positioned. Could be looking for another opportunistic acquisition in the meantime
I am in LPI and EPG for the hedging and shrewd management. Sold SN too early on their huge run
Sentiment: Strong Buy
They have confirmed that their reporters are compensated in part by number of "eyeballs" attracted to the sensational headline stories.
Unfortunately, they are in the National Enquirer business model and in terms of credibility
Looks like more margin calls coupled with weak bio market
Valuation starting to look compelling again w/ risk vs reward. The results did in fact meet endpoint with some skidmarks
Made first nibble at 16....
23 to 8 in last year for this growth company. So far management has under promised and under delivered